Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Explore scenarios where incorporating mutual funds into an index-based portfolio can improve diversification and adaptability.
24,945 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
The stem (stem) 2025 earnings season offers a clear read on where AI, software, and hardware players stand. This guid...
As stocks march unfolds, the electric vehicle sector presents both challenges and opportunities. Here are two underva...
Institutional moves can reveal much about a company’s future. This article breaks down why long path partners buys Al...
Investors chase stocks with accelerating growth and clear catalysts. This guide explains how to identify a supercharg...
A sudden move lower in AeroVironment stock has traders and long-term holders asking what happened. This guide breaks ...
As Cognyte readies its Q1 2027 earnings report, investors want clarity on growth, margins, and cash flow. This guide ...
Five Below is navigating a evolving bargain-hunting landscape in 2026. This article breaks down a hypothetical Q1 202...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
The U.S. government has halted Anthropic's Fable 5 and Mythos 5, citing a security vulnerability. The move shakes fin...
A single viral moment can alter a celebrity’s financial path. This article uses holland’s viral ‘umbrella’ performanc...
Investors are eyeing the microreactor trend and Nano Nuclear Energy. This guide breaks down the potential, risks, and...